Pediatrics Doctors in Armonk, NY Accepting Medicare

4 Pediatrics doctors found. Showing 1 - 4

Dr. Samantha Cayley Lowe, M.D. Pediatrics Medicare: Medicare Enrolled Practice Location: 99 Business Park Dr, Armonk, NY 10504 Phone: 914-849-7900

Dr. Randi Salzman Feldman, M.D. Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 23 Creemer Rd, Armonk, NY 10504 Phone: 914-273-1491    Fax: 914-273-8570

Joy M Samanich, MD Pediatrics Medicare: Medicare Enrolled Practice Location: 1 Hunter Ave Ste A, Armonk, NY 10504 Phone: 914-236-0336    Fax: 914-940-0330

Dr. Ellen P Lestz, M.D. Pediatrics - Adolescent Medicine Medicare: Medicare Enrolled Practice Location: 99 Business Park Dr, Armonk, NY 10504 Phone: 914-849-7900    Fax: 914-849-7995

News Archive

Study: Stem cell transplant heals neurological deficits in mice

For the first time, human embryonic stem cells have been transformed into nerve cells that helped mice regain the ability to learn and remember.

Gladstone Institutes, H. Lundbeck collaborate to identify therapeutic candidates for neurological diseases

The Gladstone Institutes and the international pharmaceutical company H. Lundbeck A/S have announced a collaborative research agreement to study and identify therapeutic candidates for neurological diseases. The agreement funds research at the Gladstone Center for Translational Research led by Gladstone investigator Katerina Akassoglou, PhD, and establishes the new Lundbeck Center for Neurovascular and Immuno-imaging at the Gladstone Institute of Neurological Disease.

Coloplast announces launch of most compact catheter for men in the U.S.

Coloplast announced the U.S. launch of SpeediCath Compact Male, the most compact catheter for men, designed so users can do more. The new product is less than half the size of a standard male catheter and may be stored, carried, used and disposed of more discreetly.

Traversa Therapeutics, sanofi-aventis sign agreement for development of PTD-DRBD RNAi delivery technology

Traversa Therapeutics announced today the signing of a research agreement with sanofi-aventis for the validation and development of Traversa's RNAi delivery technology: PTD-DRBD. Under the agreement, the companies will study short interfering RNA (siRNA) complexed to PTD-DRBD, with the ultimate goal of developing drugs using this technology.

New approach compares changes in neural connectivity using concurrent EEG and fMRI imaging

New research demonstrates how two vastly different methods of measuring brain activity can provide meaningful data on brain networks simultaneously.

Read more Medical News

› Verified 5 days ago